3Kappas A, Drummond GS, Manola T, et al. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility [ J]. Pediatrics, 1988, 81(4) : 485-497.
4Suresh GK, Martin CL, Soil RF. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates [ J ]. Cochrane Database Syst Rev, 2003, (2) : CD004207.
5Schulz S, Wong RJ, Vreman I-I J, et al. Metalloporphyrins-an update [J]. Front Pharmacol, 2012, 3(68) : 1-16.
6Vreman H J, Wong R J, Stevenson DK. Alternative metalloporphyrins for the treatment of neonatal jaundice [ J ]. Journal of Perinatology, 2001, 21 (Suppl 1 ) : S108-113.
7Stevenson DK, Wong RJ. Metalloporphyrins in the management of neonatal hyperbilirubinemia [ J ]. Semin Fetal Neonatal Med, 2010, 15(3): 164-16.
8Dennery PA. Metalloporphyrins for the treatment of neonatal jaundice [J]. Curr Opin Pediatr, 2005, 17(2) : 167-169.
9Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase- deficient newborns using an inhibitor of bilirubin production, Sn- mesoporphyrin [J]. Pediatrics, 1998, 101(5) : E1.
10Morioka I, Wong R J, Abate A, et al. Systemic effects of orally- administered zinc and tin (IV) metalloporphyrins on heme oxygenase expression in mice [ J ]. Pediatr Res, 2006, 59 (5) : 667-672.
